Skip to content
Phone: +44 141 899 0081
Email: info@kinesysconsulting.com
Twitter
Linkedin
Home
Our Team
Directors & Senior Consultants
Board of Medical, Scientific & Business Advisors
Regulatory Services
Scientific Advice
Paediatric Investigation Plan
Orphan Drug
PRIME & PIM Schemes
Clinical Trial Authorisation
Marketing Authorisation Application
Oral Explanation
Strategic Services
Regulatory & Development Roadmap
Expedited Pathways
Due Diligence
Advanced Therapies
Biotechnology
Writing Services
Regulatory Writing
Marketing Authorisation
Product Information
Medical & Clinical Writing
Scientific Communications
Medical Devices
Regulatory Consultancy
Drug-Device Combinations (DDC)
CE Marking
UKCA Marking
UK Responsible Person Service
Internal and Supplier Audits
ISO 13485 Support
News
Join Us
Contact
NICE-MHRA2
Home /
NICE-MHRA2
NICE-MHRA2
Written By sonia ziouani ammor
Post navigation
Kinesys Consulting secures its first PIM designation from UK MHRA under the EAMS – Early Access to Medicines Scheme